Retraction: Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways

Retraction of ‘Ligustrazine attenuates renal damage by inhibiting endoplasmic reticulum stress in diabetic nephropathy by inactivating MAPK pathways’ by Hongling Yang et al., RSC Adv., 2018, 8, 21816–21822, DOI: 10.1039/C8RA01674G.

Detalles Bibliográficos
Autor principal: Fisher, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694327/
https://www.ncbi.nlm.nih.gov/pubmed/35426982
http://dx.doi.org/10.1039/d1ra90018h

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694327/
https://www.ncbi.nlm.nih.gov/pubmed/35426982
http://dx.doi.org/10.1039/d1ra90018h

Ejemplares similares